Ann: VIRALEZE SPL7013 highly active in UK variant of coronavirus, page-64

But hey, our illustrious leader stated the following about Viraleze in the recent AK interview 'so the US is not one of the markets we're particularly focused on for this product' ...


Look at these statistics from John Hopkins in the USA in their summer ? Imagine when they head into the fall and then of course the colder months of winter later in the year ?


https://thehill.com/policy/healthca...vid-19-cases-six-times-higher-than-last-year/

As summer begins, US COVID-19 cases six times higher than last year

BY MONIQUE BEALS - 05/29/22 6:32 PM ET


As the US marks Memorial Day weekend and the unofficial start of summer, the seven-day average for COVID-19 cases in the U.S. are more than six times what they were a year ago.

The Johns Hopkins Coronavirus Resource Center showed a seven-day average of 119,725 cases as of Saturday. That figure held at 17,887 cases on May 28 of last year.

https://coronavirus.jhu.edu/region/united-states




The Vietnam Viraleze ASX announcement focused on population and case numbers to support the "priority" needed for a rollout there but yet the USA with much higher statistics 'isn't a market we are particularly focused on' .... makes sense - NOT !





..... and wasn't BARDA touted by JF & Co. at one point for Viraleze ? Seems to have faded away into the background like DEP® Remdesivir ?